The Faces of Cardiovascular Disease

This teaser is part of a mini-series – launching in January 2019 – we are calling The Faces of Cardiovascular Disease, looking at the different presentations, symptoms, and root causes of a disease that affects millions of people around the world.

“Through this series we hope to explore the human side of the problem, to develop a deeper and more compassionate understanding of the stories behind the figures, and ultimately to better inform the products we develop.”

We have all heard the statistic; you’re more likely to die from cardiovascular disease than from any other cause.

In fact, between 1980 and 2014, 4 in 10 deaths in the United States – 31.9 million people – were a direct result of cardiovascular disease. A sobering figure, but what’s equally alarming is the acceptance of this sad reality rather than asking fundamental questions that may lead to real solutions.

To start, what’s behind these numbers? Am I at risk of suffering a heart attack? A stroke? What could cause my disease? Is it genetic? Did lifestyle choices contribute? Can I prevent this from happening?

Statistics only tell part of the story. By digging deeper into the personal stories of those affected we can uncover the root causes of cardiovascular disease and look towards more effective preventions and therapies.

As a research-based biotechnology company, Resverlogix first and foremost tries to understand the biology underlying cardiovascular disease. However, through this series we hope to explore the human side of the problem, to develop a deeper and more companionate understanding of the stories behind the figures, and ultimately to better inform the products we develop.

In the New Year, we will examine the lives of different people with cardiovascular disease and try to understand how genetic and environmental risk factors, translated through epigenetics and the intertwined processes of lipid transport, hypertension, inflammation and calcification, ultimately combine to impact their lives.